Duodenal mucosal intervention in the management of MASLD and type 2 diabetes
Duodenal mucosal treatments, in particular DMR, appear to be viable minimally invasive approaches to treat the dual metabolic loads of T2DM and MASLD. Although long-term studies with histologic outcomes in MASLD are warranted to validate the efficacy and refine patient selection criteria, these methods seem safe and beneficial.
Authors
- Saeeda Al Jaberi
- Bojia Liu
- Wei Liu (ORCID: https://orcid.org/0000-0002-7908-8476)
- Muhammad Yousaf
Institutions
- University of Southern California (US)
- Central South University (CN)
- Second Xiangya Hospital of Central South University (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1186/s13098-025-02023-w
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00